ROLE OF CARBAMOYLATING ACTIVITY FROM ANTINEOPLASTIC SULFONYLHYDRAZINES & NITROSO
ROLE OF CARBAMOYLATING ACTIVITY FROM ANTINEOPLASTIC SULFONYLHYDRAZINES & NITROSO
批准号:
8167707
负责人:
KEVIN M RICE
金额:
$13.76万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30
关键词:
Acute Myelocytic LeukemiaAntineoplastic AgentsCell DeathChemicalsClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDNA Interstrand CrosslinkingEnzymesExposure toFundingGene ExpressionGliomaGrantIn SituInstitutionInvestigationLeadNitrosourea CompoundsProcessProdrugsResearchResearch PersonnelResourcesRoleSignal PathwaySourceUnited States National Institutes of Healthbaseclinical effectcytotoxiccytotoxicitymethyl isocyanateneoplastic cellpre-clinical
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
本项目主要研究拉莫司汀的作用机制,拉莫司汀是一种磺酰肼类抗癌前药,目前正处于治疗急性髓系白血病和多形性胶质瘤的临床试验中。拉莫司汀的活性是碱催化原位活化产生的两个反应性亲电体的函数:2-氯乙基化物种和甲基异氰酸酯。2-氯乙基化物种最终形成细胞毒性的链间DNA交联物,甲基异氰酸酯的氨甲酰化活性与2-氯乙基化活性协同作用,对肿瘤细胞产生显著的细胞毒性。这些原位化学过程类似于其他抗癌化合物,包括亚硝脲。这个项目涉及到几种酶作为靶标的研究,这些酶可能被甲基异氰酸酯的氨甲酰基修饰,以解释协同细胞毒性。此外,还将阐明暴露于所研究的制剂对基因表达、信号通路和细胞死亡机制的影响。这项研究将极大地提高对这些化合物的化学反应活性与其临床前和临床效果之间关系的理解,这可能会导致更有效的化疗策略。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This project focuses on the mechanism of action of Laromustine, a sulfonylhydrazine anticancer prodrug currently in clinical trials for acute myelogenous leukemia and glioma multiforme. The activity of Laromustine is a function of two reactive electrophiles that are generated upon base-catalyzed activation in situ: a 2-chloroethylating species and methylisocyanate. The 2-chloroethylating species ultimately forms cytotoxic, interstrand DNA crosslinks, and the carbamoylating activity of methylisocyanate synergizes with the 2-chloroethylating activity, resulting in significant cytotoxicity to neoplastic cells. These in situ chemical processes are similar to those of other anticancer compounds, including nitrosoureas. This project involves an investigation of several enzymes as targets likely to be modified with a carbamoyl group from methylisocyanate so as to explain the synergistic cytotoxicity. In addition, the effects of exposure to studied agents on gene expression, signaling pathways, and cell death mechanisms will be elucidated. The research will greatly enhance the understanding of the relationship between the chemical reactivity of these compounds and their observed pre-clinical and clinical effects, which potentially could lead to more effective chemotherapeutic strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CARBAMOYLATING ACTIVITY FROM ANTINEOPLASTIC SULFONYLHYDRAZINES
-
批准号:8360308
-
项目类别:
-
资助金额:$14.06万
-
财政年份:2011
-
负责人:KEVIN M RICE
-
依托单位:
海外基金